CLINICAL_TRIALS
trial_result
· 2025-12-08
Clinical Trial Update: Pembrolizumab and EDP1503 in Advanced Melanoma [Phase 2]
Summary
Phase 2 trial of pembrolizumab in combination with EDP1503 for advanced melanoma was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Melanoma (Skin), Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2025-12-08